Figure 6.
Cross-priming using DCs loaded with killed melanoma cells. Naive CD27+CD45RA+CD8+ T cells are primed by autologous HLA-A201+ DCs loaded with killed HLA-A201− Colo829 cells. The elicited T cells are able to kill HLA-A201+ melanoma targets but not HLA-A201+ breast cancer cells or autologous monocytes.